Status: Recruiting
Mobilization and Outcomes After Venous Closure
The primary objective of this post-market registry is to collect real-world outcomes and evaluate usage practice of MYNX CONTROL™ VENOUS (MCV) Vascular Closure Device (VCD) 6F-12F in sealing femoral venous access sites in patients who have undergone endovascular procedures in a real-world setting.
Participants needed: 300
Trial details
Biological sex: AllType: ObservationalSponsor: Cordis US Corp.Updated: Mar 16, 2026Locations: 3Duration: 14 Days
Eligibility criteria
Able and willing to provide informed consent and to complete a follow-up visit a... [+3]
Presence of bruit, palpable aneurysm, significant candida or groin infection. [+4]